Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-02

Clinical Trial Results: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants [Phase 3]

View source ↗

Summary

Phase 3 study assessing RSVpreF vaccine in pregnant participants with HIV and their infants; results completed with posted findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSVpreF

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02